Update on practical aspects of the treatment of chronic myeloid leukemia with imatinib mesylate
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11899-996-0002-y.pdf
Reference71 articles.
1. Savage DG, Antman KH: Imatinib mesylate—a new oral targeted therapy. N Engl J Med 2002, 346:683–693.
2. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al.: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001, 344:1052–1056.This is the first reported case of the successful treatment of a gastrointestinal stromal tumor (GIST) with imatinib.
3. Magnusson MK, Meade KE, Brown KE, et al.: Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. Blood 2001, 98:2518–2525.
4. Ross TS, Bernard OA, Berger R, Gilliland DG: Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood 1998, 91:4419–4426.
5. Schwaller J, Anastasiadou E, Cain D, et al.: H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22). Blood 2001, 97:3910–3918.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor;Expert Opinion on Drug Safety;2016-02-27
2. Adäquate Supportivtherapie im therapeutischen Einsatz von „Biologicals“ bei gastrointestinalen(GI) Tumoren in der Onkochirurgie - Was muss der Chirurg wissen?;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2013-04-05
3. Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias;Investigational New Drugs;2012-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3